Pfizer gets EU nod for ulcerative colitis drug Velsipity Ruchika Sharma20 Feb 2024 11:30 AM ISTThe approval, applicable in all 27 countries of the European Union, is based on studies from two late-stage trials that showed the drug was effective...
AstraZeneca-Daiichi Sankyo application for Datopotamab deruxtecan accepted in US for patients with previously treated advanced nonsquamous non-small cell lung cancer Ruchika Sharma19 Feb 2024 4:30 PM ISTCambridge: AstraZeneca and Daiichi Sankyo's Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US...
India's stand on intellectual property rights, pharma help promote growth of generic industry: GTRI Report Ruchika Sharma19 Feb 2024 2:30 PM ISTNew Delhi: India's stand on intellectual property rights (IPRs) and pharma issues in proposed trade agreements balances innovation with public health...
Production at Odisha first vaccine manufacturing plant to commence by May Ruchika Sharma19 Feb 2024 1:30 PM ISTThe facility is expected to produce over 15 vaccines for various diseases, including cholera and malaria.
Delhi: DPSRU VC removed over recruitment scam Ruchika Sharma19 Feb 2024 12:30 PM ISTThe LG, the chancellor of the DPSRU, also gave his nod to filing an FIR against Goyal and six other officers named in a report by the three-member...
Should Nutraceuticals be brought under CDSCO? Government forms panel to decide Ruchika Sharma19 Feb 2024 11:30 AM ISTOfficials said due to unsupervised usage of supplements, people at the same time consume supplements along with drugs which might interact with each...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal to Study Capivasertib Plus Abiraterone Dr. Divya Colin18 Feb 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel grants Sanofi's Updated Prescribing Information for FDC Ibuprofen plus Paracetamol Dr. Divya Colin18 Feb 2024 6:00 PM ISTNew Delhi: The drug major Sanofi has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Telangana drug regulator becomes eligible to observe USFDA inspections Ruchika Sharma18 Feb 2024 11:30 AM ISTThe DCA DG said this collaboration could potentially lead to enhanced regulatory harmonisation, improved compliance with global standards, and better...
Sanofi Dupixent gets Japenese nod for chronic spontaneous urticaria Ruchika Sharma18 Feb 2024 10:00 AM ISTParis: Sanofi has announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization...
Roche Xolair gets USFDA nod for children, adults with one or more food allergies Ruchika Sharma17 Feb 2024 4:30 PM ISTIn the U.S., Genentech, a member of the Roche Group, and Novartis Pharmaceuticals Corporation work together to develop and co-promote Xolair.
Gilead Sciences pauses enrollment globally in magrolimab solid tumor studies Ruchika Sharma17 Feb 2024 2:43 PM ISTFoster City: Gilead Sciences, Inc. has announced that it has paused enrollment globally in the magrolimab solid tumor studies. The U.S. Food and Drug...
